BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 31678159)

  • 21. Molecular networking in the neuronal ceroid lipofuscinoses: insights from mammalian models and the social amoeba Dictyostelium discoideum.
    Huber RJ
    J Biomed Sci; 2020 May; 27(1):64. PubMed ID: 32430003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional biology of the neuronal ceroid lipofuscinoses (NCL) proteins.
    Kyttälä A; Lahtinen U; Braulke T; Hofmann SL
    Biochim Biophys Acta; 2006 Oct; 1762(10):920-33. PubMed ID: 16839750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The neuronal ceroid-lipofuscinoses: from past to present.
    Haltia M
    Biochim Biophys Acta; 2006 Oct; 1762(10):850-6. PubMed ID: 16908122
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progress towards understanding disease mechanisms in small vertebrate models of neuronal ceroid lipofuscinosis.
    Cooper JD; Russell C; Mitchison HM
    Biochim Biophys Acta; 2006 Oct; 1762(10):873-89. PubMed ID: 17023146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular genetics of the neuronal ceroid lipofuscinoses.
    Mole S; Gardiner M
    Epilepsia; 1999; 40 Suppl 3():29-32. PubMed ID: 10446748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Genetic Basis of Phenotypic Heterogeneity in the Neuronal Ceroid Lipofuscinoses.
    Gardner E; Mole SE
    Front Neurol; 2021; 12():754045. PubMed ID: 34733232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel MFSD8 mutation in a Russian patient with neuronal ceroid lipofuscinosis type 7: a case report.
    Kozina AA; Okuneva EG; Baryshnikova NV; Krasnenko AY; Tsukanov KY; Klimchuk OI; Kondakova OB; Larionova AN; Batysheva TT; Surkova EI; Shatalov PA; Ilinsky VV
    BMC Med Genet; 2018 Aug; 19(1):151. PubMed ID: 30144815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetics of the neuronal ceroid lipofuscinoses (Batten disease).
    Mole SE; Cotman SL
    Biochim Biophys Acta; 2015 Oct; 1852(10 Pt B):2237-41. PubMed ID: 26026925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular basis of the neuronal ceroid lipofuscinoses: mutations in CLN1, CLN2, CLN3, and CLN5.
    Mole SE; Mitchison HM; Munroe PB
    Hum Mutat; 1999; 14(3):199-215. PubMed ID: 10477428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The neuronal ceroid-lipofuscinoses: a historical introduction.
    Haltia M; Goebel HH
    Biochim Biophys Acta; 2013 Nov; 1832(11):1795-800. PubMed ID: 22959893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Canine neuronal ceroid lipofuscinoses: Promising models for preclinical testing of therapeutic interventions.
    Katz ML; Rustad E; Robinson GO; Whiting REH; Student JT; Coates JR; Narfstrom K
    Neurobiol Dis; 2017 Dec; 108():277-287. PubMed ID: 28860089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NCL disease mechanisms.
    Palmer DN; Barry LA; Tyynelä J; Cooper JD
    Biochim Biophys Acta; 2013 Nov; 1832(11):1882-93. PubMed ID: 23707513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abnormal triaging of misfolded proteins by adult neuronal ceroid lipofuscinosis-associated DNAJC5/CSPα mutants causes lipofuscin accumulation.
    Lee J; Xu Y; Saidi L; Xu M; Zinsmaier K; Ye Y
    Autophagy; 2023 Jan; 19(1):204-223. PubMed ID: 35506243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Applying modern Omic technologies to the Neuronal Ceroid Lipofuscinoses.
    Kline RA; Wishart TM; Mills K; Heywood WE
    Biochim Biophys Acta Mol Basis Dis; 2020 Sep; 1866(9):165498. PubMed ID: 31207290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuronal ceroid lipofuscinosis: impact of recent genetic advances and expansion of the clinicopathologic spectrum.
    Cotman SL; Karaa A; Staropoli JF; Sims KB
    Curr Neurol Neurosci Rep; 2013 Aug; 13(8):366. PubMed ID: 23775425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patient-Derived Induced Pluripotent Stem Cell Models for Phenotypic Screening in the Neuronal Ceroid Lipofuscinoses.
    Morsy A; Carmona AV; Trippier PC
    Molecules; 2021 Oct; 26(20):. PubMed ID: 34684815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetics of the neuronal ceroid lipofuscinoses.
    Peltonen L; Savukoski M; Vesa J
    Curr Opin Genet Dev; 2000 Jun; 10(3):299-305. PubMed ID: 10826995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular pathology and pathogenic aspects of neuronal ceroid lipofuscinoses.
    Kida E; Golabek AA; Wisniewski KE
    Adv Genet; 2001; 45():35-68. PubMed ID: 11332776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Batten disease: four genes and still counting.
    Mole SE
    Neurobiol Dis; 1998 Nov; 5(5):287-303. PubMed ID: 10069573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The contribution of multicellular model organisms to neuronal ceroid lipofuscinosis research.
    Huber RJ; Hughes SM; Liu W; Morgan A; Tuxworth RI; Russell C
    Biochim Biophys Acta Mol Basis Dis; 2020 Sep; 1866(9):165614. PubMed ID: 31783156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.